Accepted for/Published in: JMIR Medical Informatics
Date Submitted: Apr 1, 2021
Date Accepted: Feb 13, 2022
A Traditional Chinese Medicine Syndrome Classification Model based on Cross-FGCNN: Model Development and Validation
ABSTRACT
Background:
Syndrome differentiation and treatment is the core of traditional Chinese medicine (TCM) in the treatment of diseases. TCM doctors can dialectically classify the syndrome according to the patients' symptoms and conduct treatment. Syndrome differentiation can be regarded as a mathematical model for multi-classification of different high-dimensional sparse symptom vectors. The FGCNN can quickly and effectively extract the linear and nonlinear cross features of sparse vectors in the CTR task.
Objective:
We hope to standardize the symptom input of intelligent syndrome differentiation and treatment. Through the improvement of FGCNN, an intelligent dialectical processing algorithm is constructed. To assist TCM physicians in rational dialectical treatment.
Methods:
We selected the data of 5273 real cases of dysmenorrhea standardized according diagnose TCM and divided the symptoms into feild according to the four diagnosis of TCM, so as to construct an improved Cross-FGCNN model and apply it to the intelligent dialectics of TCM. We used 6 kinds of intelligent dialectical models and 3 kinds of CTR models as comparisons at the same time
Results:
Cross-FGCNN can achieve 96.21% accuracy and 0.836 Log-Loss, which is better than other models.
Conclusions:
We maintain that the model of Cross-FGCNN can automatically extract the linear and nonlinear features of symptoms and classify them, having great potential in the intelligent dialectics of TCM in the future.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.